Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Dieterich, J.
3321  Ergebnisse:
englisch X
Personensuche X
?
1

Relevance and limits of patient surveys within humanitarian..:

Dieterich, A
European Journal of Public Health.  32 (2022)  Supplement_3 - p. , 2022
Link: https://doi.org/10.1093/..
 
?
2

PIN8 HEPATITIS B TREATMENT PATTERNS IN US CLINICAL CARE FOL..:

Curry, M. ; Bae, H. ; Dieterich, D....
Value in Health.  23 (2020)  - p. S169 , 2020
Link: https://doi.org/10.1016/..
 
?
3

PIN9 CLINICAL PRACTICE EXPERIENCE WITH TENOFOVIR ALAFENAMID..:

Curry, M. ; Bae, H. ; Dieterich, D....
Value in Health.  22 (2019)  - p. S196 , 2019
Link: https://doi.org/10.1016/..
 
?
4

PIN26 COST-MINIMIZATION ANALYSIS OF PAN-GENOTYPIC TREATMENT..:

Gordon, S. ; Smith, N. ; Dieterich, D.
Value in Health.  22 (2019)  - p. S198 , 2019
Link: https://doi.org/10.1016/..
 
?
5

Utilization of DAA therapies ledipasvir/sofosbuvir and sofo..:

Tsai, N. ; Bacon, B. ; Curry, M....
Journal of Hepatology.  66 (2017)  1 - p. S726 , 2017
Link: https://doi.org/10.1016/..
 
?
6

Utilization of sofosbuvir/velpatasvir in genotype 2–6 HCV: ..:

Curry, M. ; Bacon, B. ; Dieterich, D....
Journal of Hepatology.  66 (2017)  1 - p. S58 , 2017
Link: https://doi.org/10.1016/..
 
?
7

Elbasvir/Grazoprevir effectiveness in patients with Chronic..:

Younossi, Z. ; Bacon, B. ; Curry, M....
Journal of Hepatology.  66 (2017)  1 - p. S748-S749 , 2017
Link: https://doi.org/10.1016/..
 
?
8

Effectiveness of 8‐ or 12‐weeks of ledipasvir and sofosbuvi..:

Curry, M. P. ; Tapper, E. B. ; Bacon, B....
Alimentary Pharmacology & Therapeutics.  46 (2017)  5 - p. 540-548 , 2017
Link: https://doi.org/10.1111/..
 
?
9

A systematic model improves hepatitis C virus birth cohort ..:

Goel, A. ; Sanchez, J. ; Paulino, L....
Journal of Viral Hepatitis.  24 (2017)  6 - p. 477-485 , 2017
Link: https://doi.org/10.1111/..
 
?
10

Real-world treatment utilization and results in the renaiss..:

Flamm, S. ; Bacon, B. ; Curry, M....
Journal of Hepatology.  66 (2017)  1 - p. S740-S741 , 2017
Link: https://doi.org/10.1016/..
 
?
11

Real-world use of elbasvir/grazoprevir and outcomes in pati..:

Bacon, B. ; Curry, M. ; Dieterich, D....
Journal of Hepatology.  66 (2017)  1 - p. S295 , 2017
Link: https://doi.org/10.1016/..
 
?
12

Cubic spline approximation of a circle with maximal smoothn..:

Apprich, C. ; Dieterich, A. ; Höllig, K..
Computer Aided Geometric Design.  56 (2017)  - p. 1-3 , 2017
Link: https://doi.org/10.1016/..
 
?
13

Real‐world effectiveness of ombitasvir/paritaprevir/ritonav..:

Wedemeyer, H. ; Craxí, A. ; Zuckerman, E....
Journal of Viral Hepatitis.  24 (2017)  11 - p. 936-943 , 2017
Link: https://doi.org/10.1111/..
 
?
14

Ledipasvir/Sofosbuvir ± Ribavirin in HCV Post-Transplant Pa..:

Flamm, S. ; Bacon, B. ; Curry, M....
Journal of Hepatology.  64 (2016)  2 - p. S822-S823 , 2016
Link: https://doi.org/10.1016/..
 
?
15

EFFECTIVENESS OF 12 OR 24 WEEK LDV/SOF AND 12 WEEK LDV/SOF+..:

Curry, M. ; Bacon, B. ; Dieterich, D....
Value in Health.  19 (2016)  3 - p. A312-A313 , 2016
Link: https://doi.org/10.1016/..
 
1-15